NVTA vs. CNTG, MDXH, LH, DGX, NTRA, EXAS, RDNT, GH, FTRE, and VCYT
Should you be buying Invitae stock or one of its competitors? The main competitors of Invitae include Centogene (CNTG), MDxHealth (MDXH), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Natera (NTRA), Exact Sciences (EXAS), RadNet (RDNT), Guardant Health (GH), Fortrea (FTRE), and Veracyte (VCYT). These companies are all part of the "medical laboratories" industry.
Invitae (NYSE:NVTA) and Centogene (NASDAQ:CNTG) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.
61.3% of Invitae shares are owned by institutional investors. Comparatively, 9.9% of Centogene shares are owned by institutional investors. 0.7% of Invitae shares are owned by insiders. Comparatively, 1.9% of Centogene shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Centogene has lower revenue, but higher earnings than Invitae.
Invitae received 411 more outperform votes than Centogene when rated by MarketBeat users. However, 64.52% of users gave Centogene an outperform vote while only 60.05% of users gave Invitae an outperform vote.
In the previous week, Centogene had 1 more articles in the media than Invitae. MarketBeat recorded 2 mentions for Centogene and 1 mentions for Invitae. Centogene's average media sentiment score of 1.43 beat Invitae's score of 0.00 indicating that Centogene is being referred to more favorably in the news media.
Invitae has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Comparatively, Centogene has a beta of -0.67, suggesting that its share price is 167% less volatile than the S&P 500.
Invitae currently has a consensus target price of $1.00, suggesting a potential upside of 333,233.33%. Given Invitae's higher probable upside, equities research analysts clearly believe Invitae is more favorable than Centogene.
Centogene has a net margin of 0.00% compared to Invitae's net margin of -299.14%. Centogene's return on equity of 0.00% beat Invitae's return on equity.
Summary
Centogene beats Invitae on 8 of the 13 factors compared between the two stocks.
Get Invitae News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
Free NVTA Stock Alerts